Sermorelin vs. Semaglutide: Can You Take Them Both? (Benefits and Considerations)

What is Sermorelin?

Sermorelin is a synthetic form of growth hormone-releasing hormone (GHRH), or a 29-amino acid peptide which functions by stimulating the pituitary gland’s natural production of human growth hormone. It may be used to diagnose and treat growth hormone deficiency in children in certain circumstances may be prescribed by a licensed healthcare provider to adults. The side effects of sermorelin may include injection site reactions (redness, swelling, or pain), headache, flushing, dizziness, nausea, fatigue, sleep disturbances, increased appetite, joint pain, and allergic reactions such as rash or difficulty breathing.

Sermorelin therapy is a hormone optimization therapy, functioning as a synthetic analog of growth hormone-releasing hormone (GHRH) which stimulates the body's natural hormone production mechanisms. This hormone works by binding to specific receptors in the brain, triggering the pituitary gland to release growth hormone

Used for treating growth hormone deficiency, sermorelin has shown success, with studies indicating improved growth rates in 74% of children after six months of treatment. The medication works by binding to specific receptors on the pituitary gland, effectively enhancing the body's natural hormone production processes.

It may be prescribed by a licensed healthcare provider in limited circumstances for adults. 

Sermorelin dosage may typically include doses ranging from 200 to 300 mcg administered daily via subcutaneous injection, or as prescribed by a licensed healthcare provider. While how long sermorelin stays in your system is relatively short, with a half-life of 10-20 minutes, its effects on growth hormone release may last for several hours. 

The administration of sermorelin is typically through subcutaneous injection once daily, potentially in the evening to align with the body's natural hormone production patterns, or as prescribed by a licensed healthcare provider. 

‍

Does sermorelin increase appetite or does sermorelin make you hungry?

One side effect of sermorelin may be increased appetite - please consult your licensed healthcare provider to understand the effects of sermorelin. 

‍

What is compounded semaglutide?

Compounded semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1). It is available in compounded form. 

First approved by the FDA in 2017 and branded as Ozempic(R) for T2 diabetes control and WeGovy(R) for weight management, it may also be available as prescribed by a licensed healthcare provider as compounded semaglutide for type 2 diabetes and weight management. Compounded semaglutide contains the same active ingredient as the trademarked medications. Compounded semaglutide is not approved by the FDA for effectiveness, safety or quality. 

‍

Compounded semaglutide may be available with additional supplements such as B12 for enhanced benefits. The medication works through multiple mechanisms to achieve its therapeutic effects:

• Increases insulin production when blood sugar is elevated
• Reduces appetite through brain receptor activation
• Slows gastric emptying for prolonged satiety
• Suppresses glucagon release for better blood sugar control

‍

Currently, semaglutide is available in three FDA-approved formulations: Wegovy® for weight loss, Ozempic® for diabetes control, and Rybelsus® as an oral option. 

For optimal results, healthcare providers may prescribe compounded semaglutide as part of a personalized treatment plan which includes dietary modifications and regular physical activity. 

Understanding how long it takes for compounded semaglutide to work is crucial for patient expectations. Most individuals may begin to notice weight loss effects over 8-12 weeks of starting treatment, with results typically observed over several months of consistent use.

‍

Does compounded semaglutide affect hormones?

Compounded semaglutide may influence various hormonal systems in the body. While its primary action is on GLP-1 receptors, it may indirectly affect other hormones. Some patients report changes in their menstrual cycle, leading to questions about compounded semaglutide and periods. Women should discuss any menstrual irregularities with their healthcare provider.

‍

How long does it take for compounded semaglutide to work?

Understanding compounded semaglutide dosages is essential to ensure effective and safe use, as the proper dosage can vary based on individual health needs and goals. 

The timeline for compounded semaglutide's effects can vary among individuals. Generally, patients may begin to notice changes in appetite and weight within 8-12 weeks of starting treatment as mentioned earlier. 

‍

Differences Between Sermorelin and compounded semaglutide

While both medications contribute to metabolic health, their fundamental mechanisms of action differ significantly. The primary distinction lies in their cellular targets and physiological effects on the body.

Compounded semaglutide may be available for management of T2 diabetes or weight management. Sermorelin may be available to treat growth hormone deficiency in children in certain circumstances may be prescribed by a licensed healthcare provider to adults. Sermorelin may support healthy growth hormone levels, muscle enhancement and overall well-being. 

Differences between sermorelin vs compounded semaglutide include:

• Mechanism of Action: Sermorelin stimulates natural human growth hormone (HGH) production from the pituitary gland, while compounded semaglutide mimics glucagon-like peptide-1 (GLP-1) to regulate blood sugar and appetite

‍

‍

‍

Can Sermorelin and Compounded Semaglutide be Taken Together?

Anyone considering either or both medications must consult a licensed healthcare provider, who will evaluate their individual health needs and determine whether they may or may not be eligible for either or both medications.

‍

Side Effects

Understanding potential risks and sermorelin side effects is crucial for patients considering combination therapy with sermorelin and compounded semaglutide. 

The side effects of sermorelin may include injection site reactions (redness, swelling, or pain), headache, flushing, dizziness, nausea, fatigue, sleep disturbances, increased appetite, joint pain, and allergic reactions such as rash or difficulty breathing.

The side effects of compounded semaglutide include possible thyroid tumors, including cancer, pancreatitis, changes in vision, low blood sugar, kidney problems, and serious allergic reactions. 

‍

Other common side effects of both may include:

• Gastrointestinal side effects:
• Nausea and vomitingsome text
  • Diarrhea
  • Abdominal discomfort
• Injection site reactions
• Headaches
• Fluid retention

More serious potential risks include pancreatic complications, diabetic retinopathy issues, and kidney problems when using compounded semaglutide. Additionally, sermorelin may cause joint stiffness and carpal tunnel syndrome in some patients.

‍

Medical Monitoring Requirements

Anyone considering either medication must consult a licensed healthcare provider, who will evaluate their individual health needs and determine whether they may or may not be eligible for either or both medications.

Regular assessment should include:

• Blood Sugar Monitoring: Frequent testing to maintain stable glucose levels
• Cardiovascular Function: Regular monitoring due to potential fluid retention effects
• Hormone Levels: Careful tracking of growth hormone and related markers

‍

Final Thoughts

Both medications have distinct uses, each designed to address specific medical conditions or health needs. Anyone considering either medication must consult a licensed healthcare provider, who will evaluate their individual health needs and determine whether they may or may not be eligible for either or both medications.

Regular monitoring of blood glucose levels, hormone markers, and potential side effects may help ensure treatment outcomes.

‍

FAQ

Can I take sermorelin and compounded semaglutide together? 

Both medications serve different purposes—sermorelin for healthy growth hormone levels in children, and may be prescribed to adults in limited situations; and compounded semaglutide for weight loss. 

Anyone considering either medication must consult a licensed healthcare provider, who will evaluate their individual health needs and determine whether they may or may not be eligible for either or both medications.

‍

What shouldn't you mix with compounded semaglutide?

Certain foods and substances may be limited or avoided while taking compounded semaglutide to maximize effectiveness and minimize side effects. Healthcare providers may recommend combining compounded semaglutide with a proper diet and exercise while avoiding or limiting: 

• High-fat and greasy foods
• Alcohol consumption
• Sugar-sweetened beverages
• Ultra-processed foods 

Additionally, patients should be aware that compounded semaglutide may affect thyroid functionality and potentially interact with medications for hypothyroidism. 

‍

Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.

‍

References

‍

1.

Lyons SA, Beaudry JL. Synergistic Combinations of Gut- and Pancreas-Hormone-Based Therapies: Advancements in Treatments for Metabolic Diseases. Endocrinology. 2023;164(11). https://academic.oup.com/endo/article/164/11/bqad153/7308590?login=false

2.

Drugs.com. Ozempic and sermorelin Interactions. Accessed December 7, 2024. https://www.drugs.com/drug-interactions/ozempic-with-sermorelin-3878-18733-2055-0.html

3.

Ishida J, Saitoh M, Ebner N, Springer J, Anker SD, von Haehling S. Growth hormone secretagogues: history, mechanism of action, and clinical development. JCSM Rapid Communications. 2020;3(1):25-37. https://onlinelibrary.wiley.com/doi/10.1002/rco2.9

4.

International Antiaging Systems. Dr Ward Dean Q&A. Accessed December 7, 2024. https://www.antiaging-systems.com/ask-dr-ward-dean

5.

Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clinical interventions in aging. 2006;1(4):307-308. https://pmc.ncbi.nlm.nih.gov/articles/PMC2699646/

6.

Aaseth J, Ellefsen S, Alehagen U, Sundfr TM, Alexander J. Diets and drugs for weight loss and health in obesity – An update. Biomedicine & Pharmacotherapy. 2021;140:111789. https://www.sciencedirect.com/science/article/pii/S0753332221005710?via%3Dihub

7.

Drugs.com. compounded semaglutide and sermorelin Interactions. Accessed December 7, 2024. https://www.drugs.com/drug-interactions/compounded semaglutide-with-sermorelin-3878-0-2055-0.html

8.

Ryan DH, Lingvay I, Deanfield J, et al. Long-term weight loss effects of compounded semaglutide in obesity without diabetes in the SELECT trial. Nature Medicine. 2024;30(7):2049-2057. https://www.nature.com/articles/s41591-024-02996-7

9.

Ghusn W, De la Rosa A, Sacoto D, et al. Weight Loss Outcomes Associated With compounded semaglutide Treatment for Patients With Overweight or Obesity. JAMA Network Open. 2022;5(9):e2231982. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2796491

10.

Ghusn W, Rosa AD la, Sacoto D, et al. Weight Loss Outcomes Associated With compounded semaglutide Treatment for Patients With Overweight or Obesity. JAMA network open. 2022;5(9):e2231982-e2231982. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2796491

11.

American Kidney Fund. Study results show promising effects of compounded semaglutide for people with diabetic kidney disease. Published online March 22, 2024. Accessed December 7, 2024. https://www.kidneyfund.org/article/study-results-show-promising-effects-compounded semaglutide-people-diabetic-kidney-disease

12.

FDA Office of the Commissioner. FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014. FDA. Published online June 21, 2021. Accessed December 7, 2024. https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014

13.

AJMC. compounded semaglutide Eligibility Expands to Over Half of US Adults. Published online November 21, 2024. Accessed December 7, 2024. https://www.ajmc.com/view/compounded semaglutide-eligibility-expands-to-over-half-of-us-adults

14.

novoMEDLINK. compounded semaglutide Medications. Accessed December 7, 2024. https://www.novomedlink.com/compounded semaglutide/medicines.html?&utm_source=google&utm_medium=cpc&utm_term=genuine%20compounded semaglutide&utm_campaign=1_All_Shared_BR_compounded semaglutide_General&mkwid=s-dc_pcrid_675991957411_pkw_genuine%20compounded semaglutide_pmt_p_slid__product_&pgrid=154113488317&ptaid=kwd-2210241531535&gad_source=1&gclid=Cj0KCQiA3sq6BhD2ARIsAJ8MRwXZNeEpPc8MBV_07mI9pZFyuHQYaF8uznY5lRjtRRxwWxfcFYFOHJ4aAh-cEALw_wcB&gclsrc=aw.ds

15.

Drugs.com. Sermorelin Interactions Checker. Accessed December 7, 2024. https://www.drugs.com/drug-interactions/sermorelin.html

16.

Thorner M, Rochiccioli P, Colle M, et al. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. The Journal of Clinical Endocrinology & Metabolism. 1996;81(3):1189-1196. https://academic.oup.com/jcem/article-abstract/81/3/1189/2649680?redirectedFrom=fulltext&login=false

17.

Holdsworth D. Traditional medicinal plants used in the treatment of gastric ailments. Papua and New Guinea medical journal. 1978;21(2):175-183. Accessed December 7, 2024. https://www.ncbi.nlm.nih.gov/books/NBK279163

18.

Brayden D, Hill T, Fairlie D, Maher S, Mrsny R. Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches. Advanced Drug Delivery Reviews. 2020;157:2-36. https://www.sciencedirect.com/science/article/pii/S0169409X20300405

19.

Jensen L, Kupcova V, Arold G, Pettersson J, Hjerpsted JB. Pharmacokinetics and tolerability of compounded semaglutide in people with hepatic impairment. Diabetes, Obesity and Metabolism. 2018;20(4):998-1005. https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.13186

20.

Rubino D, Abrahamsson N, Davies M, et al. Effect of Continued Weekly Subcutaneous compounded semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity. JAMA. 2021;325(14):1414. https://jamanetwork.com/journals/jama/fullarticle/2777886

‍

21.

Rubino D, Abrahamsson N, Davies M, et al. Effect of Continued Weekly Subcutaneous compounded semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity. JAMA. 2021;325(14):1414. https://jamanetwork.com/journals/jama/fullarticle/2777886                             

‍